Inactive Instrument

News Chinook Therapeutics, Inc.

Stocks

KDNY

US16961L1061

Biotechnology & Medical Research

All News

Apr. 21	Rigetti & Co, LLC Enters Sublease Agreement with Chinook Therapeutics, Inc	CI
23-08-14	Novartis Completes Acquisition of Chinook Therapeutics	AQ
23-08-11	Chinook Therapeutics, Inc. Announces Board Cessations	CI
23-08-11	Chinook Therapeutics, Inc.(NasdaqGM:KDNY) dropped from NASDAQ Composite Index	CI
23-08-10	Novartis AG completed the acquisition of Chinook Therapeutics, Inc. from a group of shareholders.	CI
23-08-10	Chinook Therapeutics, Inc.(NasdaqGS:KDNY) dropped from S&P Global BMI Index	CI
23-08-10	Chinook Therapeutics, Inc.(NasdaqGS:KDNY) dropped from S&P TMI Index	CI
23-08-10	Chinook Therapeutics, Inc.(NasdaqGS:KDNY) dropped from S&P Biotechnology Select Industry Index	CI
23-08-09	Chinook Therapeutics, Inc.(NasdaqGS:KDNY) dropped from NASDAQ Biotechnology Index	CI
23-08-08	Chinook: Q2 Earnings Snapshot	AQ
23-08-08	Wedbush Downgrades Chinook Therapeutics to Neutral From Outperform as Sale to Novartis Draws Closer; Keeps $42 Price Target	MT
23-08-07	Chinook Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-08-01	Wells Fargo Downgrades Chinook Therapeutics to Equalweight From Overweight, Adjusts Price Target to $40 From $30	MT
23-07-28	Chinook Therapeutics Says First Patient Enrolled in Phase 3 Trial of Zigakibart to Treat IgA Nephropathy	MT
23-07-28	Chinook Therapeutics, Inc. Announces the First Patient Enrolled in its Phase 3 Second Study of Zigakibart (BION-1301) for Patients with IgA Nephropathy	CI
23-07-28	Chinook Therapeutics Announces First Patient Enrolled in Pivotal Phase 3 BEYOND Study of Zigakibart (BION-1301) for Patients with IgA Nephropathy	AQ
23-07-21	CHINOOK THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chinook Therapeutics, Inc. - KDNY	BU
23-06-23	Chinook Therapeutics, Inc.(NasdaqGS:KDNY) added to Russell 3000E Growth Index	CI
23-06-23	Chinook Therapeutics, Inc.(NasdaqGS:KDNY) dropped from Russell 3000E Index	CI
23-06-23	Chinook Therapeutics, Inc.(NasdaqGS:KDNY) dropped from Russell Microcap Index	CI
23-06-23	Chinook Therapeutics, Inc.(NasdaqGS:KDNY) dropped from Russell Microcap Value Index	CI
23-06-23	Chinook Therapeutics, Inc.(NasdaqGS:KDNY) dropped from Russell 3000E Value Index	CI
23-06-23	Chinook Therapeutics, Inc.(NasdaqGS:KDNY) added to Russell 3000 Growth Index	CI
23-06-23	Chinook Therapeutics, Inc.(NasdaqGS:KDNY) added to Russell 2500 Growth Index	CI
23-06-23	Chinook Therapeutics, Inc.(NasdaqGS:KDNY) added to Russell Small Cap Comp Growth Index	CI